Business
ProAxsis Forms Scientific Advisory Board
ProAxsis Forms Scientific Advisory Board.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \nRNS Number : 4656T NetScientific PLC 30 March 2016 \n\n \n \n(\"Netscientific\" or the \"Group\")\n \nProAxsis Forms Scientific Advisory Board to Provide Strategic Guidance\nLondon, UK - 30 March 2016 - NetScientific plc (AIM: NSCI), the transatlantic biomedical and healthcare technology group, notes its Diagnostics portfolio company, ProAxsis, has announced the formation of a Scientific Advisory Board to support ProAxsis in the development of its ProteaseTag® activity-based immunoassays and point-of-care tests, including those designed for the detection and measurement of active Neutrophil Elastase.\nCommenting on the news, NetScientific's Chief Executive Officer, Francois R. Martelet said: \"ProAxsis' ProteaseTag® tests have the potential to greatly improve the routine monitoring of patients with serious chronic diseases such as cystic fibrosis and COPD. In bringing together this hugely respected group of clinicians specialising in CF and respiratory diseases, ProAxsis' will ensure it has world class guidance as it continues to realise this potential.\" \nThe full text of the announcement issued by ProAxsis on 30 March 2016 can be found below:\n \n \nProAxsis appoints world-renowned respiratory experts for new Scientific Advisory Board\nDate: March 30, 2016 \nProAxsis today announced the establishment of a Scientific Advisory Board (SAB), made up of world-renowned clinicians and researchers in the field of chronic respiratory disease. This newly created SAB will support ProAxsis in the development of its ProteaseTag® activity-based immunoassays and point-of-care tests, including those designed for the detection and measurement of active Neutrophil Elastase.\nThe founding ProAxsis SAB members are:\nStuart Elborn\nProfessor Elborn is Dean of the School of Medicine, Dentistry and Biomedical Sciences at Queen's University, Belfast. He was one of the longest-serving Presidents of the European Cystic Fibrosis Society, holding the role between 2008 and 2015. His primary research focus is on Cystic Fibrosis and Bronchiectasis, and in particular, increasing the understanding of the pathophysiology of infection and inflammation within these diseases, and the translation of new therapies in to clinical practice.\nScott Sagel\nDr Sagel is a pediatric pulmonologist who focuses ...